Chronic Rhinosinusitis Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You (or a legal representative on your behalf) are willing and able to give consent to participate, following local rules
• You have been treated with, or are planned to be treated with, a specific Medtronic medical device used in this study
• You sign up for the study within the required time window around your treatment
• You have been diagnosed with chronic rhinosinusitis (a long-term sinus condition) and your doctor has recommended a type of sinus surgery called FESS as standard care in Japan
• Your sinus surgery was completed successfully, without any serious complications that could affect the study results
• During surgery, 2 to 4 small medicated implants were successfully placed in your sinuses (one per sinus), following the manufacturer's instructions
• A specific packing material called NOVAPAK was the only material used to control bleeding, placed on both sides of your ethmoid sinuses (a group of small sinuses behind your nose)

Who may not be able to join:

• You have a serious health condition that may affect your survival or your ability to attend all follow-up appointments over the 6-month study period
• Local laws in your area prevent participation in this type of study
• You are already taking part in, or planning to join, another study that could interfere with this trial's results
• You received a biologic medication (a type of injection or infusion treatment) approved for chronic sinusitis with nasal polyps — such as dupilumab or mepolizumab — within the 12 weeks before your surgery visit
• You have any medical reason that means you should not use the PROPEL implants or NOVAPAK product, based on the manufacturer's guidelines (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.